Paper Details

  1. Home
  2. Paper Details

Lamotrigine for schizophrenia.

Author: PickJ, PremkumarT S

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This review of five trials comparing lamotrigine with placebo or other antipsychotic augmentation strategies for people with schizophrenia found that lamotrigine was associated with a significant reduction in PANSS total scores, positive symptom sub-scale scores, and negative symptom sub-scale scores. However, the evidence for lamotrigine as an adjuvant for people with schizophrenia is not robust, and large well-designed, conducted, and reported real-world randomized trials are needed to determine its place in everyday clinical practice.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Treating the 20-30% of people with schizophrenia whose symptoms are resistant to treatment can be problematic. Adding lamotrigine to ongoing antipsychotic treatment has shown to be of benefit in preliminary studies. OBJECTIVES: To evaluate the effects of adjuvant lamotrigine for people ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD005962.pub2

データ提供：米国国立医学図書館（NLM）

Lamotrigine: A Potential New Path for Schizophrenia Treatment

Schizophrenia, a complex mental illness that can feel like navigating a labyrinthine desert of thoughts and emotions, presents significant challenges for treatment. This review, like a research team seeking to shed light on this challenging condition, examines the potential of lamotrigine, an anticonvulsant medication, as an adjuvant treatment for schizophrenia. The authors reviewed five clinical randomized trials investigating the efficacy of lamotrigine as an augmentation strategy for individuals with schizophrenia whose symptoms are resistant to traditional antipsychotic treatment. Their findings suggest that lamotrigine may offer some benefits in reducing symptoms, but further research is needed to clarify its role in clinical practice.

Lamotrigine: A Potential Ally in the Battle Against Schizophrenia

This research, like a desert oasis offering a glimmer of hope in the face of adversity, suggests that lamotrigine may provide a valuable tool for managing schizophrenia. However, the limited evidence available necessitates further research to definitively establish its efficacy and determine its appropriate role in clinical practice.

Navigating Mental Illness: A Journey of Personalized Care

This review emphasizes the importance of personalized care for individuals living with mental illness. By understanding the potential benefits and risks of different treatment options, healthcare providers can work collaboratively with patients to tailor treatment plans to their specific needs and preferences.

Dr.Camel's Conclusion

Lamotrigine, like a desert mirage offering a potential path to relief from schizophrenia, requires further exploration to clarify its role in clinical practice. This review encourages continued research and a personalized approach to treating this complex mental illness, providing hope for individuals navigating the challenges of schizophrenia.

Date :
  1. Date Completed 2007-01-19
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

17054266

DOI: Digital Object Identifier

10.1002/14651858.CD005962.pub2

Related Literature

Article Analysis
・Effective treatment of schizophrenia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.